Benitec Biopharma Inc. (BNTC) Cash Flow Statement
Benitec Biopharma Inc. (BNTC) generated -$16.5M of operating cash flow over the twelve months to 2026-06-30, spent $105000 on capital expenditure and had free cash flow of -$16.6M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
BNTCBenitec Biopharma Inc.Follow BNTC — free
—
Price chart with a free account
- Market cap
- 301.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 12 Nov, in 19 days
| Line | FY2020 Jun 20 | FY2021 Jun 21 | FY2022 Jun 22 | FY2023 Jun 23 | FY2024 Jun 24 | FY2025 Jun 25 | FY2026 Jun 26 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -7.5 | -12.8 | -15.9 | -18.0 | -19.4 | -23.6 | -16.5 | -16.5 | |
| Capital expenditure | 0.1 | 0.2 | 0.0 | 0.0 | 0.2 | 0.0 | 0.1 | -0.1 | |
| Free cash flow | -7.6 | -13.1 | -15.9 | -18.0 | -19.6 | -23.6 | -16.6 | -16.6 | |
| Stock-based compensation | 0.2 | 0.6 | 0.9 | 0.5 | 0.8 | 17.4 | 26.4 | — |
USD millions · SEC XBRL
Benitec Biopharma Inc. — questions
- What is Benitec Biopharma Inc.'s operating cash flow?
- -$16.5M over the twelve months to 2026-06-30.
- How much does Benitec Biopharma Inc. spend on capital expenditure?
- $105000 over the twelve months to 2026-06-30.
- What is Benitec Biopharma Inc.'s free cash flow?
- -$16.6M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Benitec Biopharma Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.